In November 2025, the Australian Department of Veterans' Affairs (DVA) became the first government payer in the world to fund ...

On Tuesday, an expert panel advising the Food and Drug Administration (FDA) on the use of MDMA, or ecstasy, in combination with talk therapy to treat post-traumatic stress disorder rejected the ...

Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of using mind-altering ...

A decades-long campaign to legalize MDMA as a mainstream medical treatment will reach a climax as soon as Friday, with the Food and Drug Administration poised to decide whether the psychedelic should ...

The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news ...

Also known as molly or ecstasy, MDMA has the potential to treat post-traumatic stress disorder (PTSD). But psychedelic-assisted therapy can only be administered by a trained professional. Without the ...

The use of MDMA as a treatment for post-traumatic stress disorder (PTSD) has been rejected by a U.S. Food and Drug Administration (FDA) committee following recent trials. The decision was made at an ...

Following a poor showing for Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder at a recent FDA advisory committee meeting, the other shoe has dropped. Friday, the FDA declined to ...

VANCOUVER, BC, May 30, 2024 /PRNewswire/ - Numinus Wellness Inc. (NUMI:CA) ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative ...

In a show of bipartisanship, 80 members of Congress from both sides of the aisle have united in letters urging President Joe Biden and the US Food and Drug Administration to further consider studies ...

The Defense Department is committing two $4.9 million grants to study the effects of MDMA on post-traumatic stress disorder, one of which will enroll active-duty troops as subjects. Pictured is ...

The FDA's decision on MDMA therapy for PTSD is imminent, impacting MindMed investors and the psychedelic medicine industry. An FDA advisory committee voted against approving MDMA therapy, causing ...